SCHEMBL29622012

SCHEMBL29622012

Nc1cc(Cl)c(Oc2ccc3c(c2Cl)C2(CC2)C(=O)N3)c(Cl)c1

nearest known ligand 0.38

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
PGR P06401 4/20 0.38
IP6K1 Q92551 6/20 0.33
MET P08581 3/20 0.31
IP6K3 Q96PC2 1/20 0.30
IP6K2 Q9UHH9 1/20 0.30
AXL P30530 1/20 0.30
ALK Q9UM73 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29622001 0.88 PGR (0.36) PGRIP6K1MET
SCHEMBL29621882 0.88 IP6K1 (0.40) PGRIP6K1METAXLALK
SCHEMBL29621848 0.84 PGR (0.36) PGRIP6K1
SCHEMBL29621974 0.83 PGR (0.39) PGRIP6K1
SCHEMBL29622045 0.83 PGR (0.39) PGRIP6K1METAXLALK
SCHEMBL29621897 0.83 PGR (0.41) PGR
SCHEMBL24424354 0.79 THRB (0.52) MET
SCHEMBL28530057 0.77 PGR (0.46) PGRIP6K1IP6K3IP6K2
SCHEMBL29622021 0.77 PGR (0.46) PGRIP6K1IP6K3IP6K2
SCHEMBL29076792 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4240722-A1 OXINDOLES AND METHODS OF USE THEREOF Aligos Therapeutics, Inc. (US) 2023-09-13 EP disclosed
WO-2022099066-A1 OXINDOLES AND METHODS OF USE THEREOF ALIGOS THERAPEUTICS, INC. (US) 2022-05-12 WO disclosed